D Bignardi Selected Research

D Bignardi Research Topics

14	Hypersensitivity (Allergy) 01/2024 - 04/2009
3	Anaphylaxis (Anaphylactic Shock) 03/2023 - 01/2016
3	Drug Hypersensitivity (Drug Allergy) 03/2017 - 04/2009
2	Immediate Hypersensitivity 03/2023 - 11/2014
2	Urticaria (Hives) 03/2017 - 01/2016
2	Angioedema 03/2017 - 01/2016
2	Asthma (Bronchial Asthma) 01/2016 - 08/2013
1	COVID-19 03/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2017
1	Bronchial Spasm 03/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2017
1	Hypotension (Low Blood Pressure) 01/2016
1	Food Hypersensitivity (Food Allergy) 08/2013
1	Multiple Sclerosis 02/2012
1	Rhinitis 06/2000
1	Ischemia 04/2000
1	Disease Progression 04/2000
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2000

2	Arthropod VenomsIBA 01/2024 - 01/2019
2	Contrast MediaIBA 03/2022 - 03/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019 - 01/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2017 - 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2023
1	Polysorbates (PSML)FDA Link 03/2023
1	COVID-19 VaccinesIBA 03/2023
1	Excipients (Suspending Agents)IBA 03/2023
1	Immunoglobulin E (IgE)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 12/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2017
1	AllergensIBA 01/2016
1	LatexIBA 01/2016
1	ponceau 4R (E 124)IBA 11/2014
1	Coloring Agents (Dyes)IBA 11/2014
1	Carmine (Natural Red 4)IBA 11/2014
1	PowdersIBA 08/2013
1	Bovine Serum AlbuminIBA 08/2013
1	Natalizumab (Tysabri)FDA Link 02/2012
1	Monoclonal AntibodiesIBA 02/2012
1	Phenobarbital (Luminal)FDA Link 04/2009
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2009

2	Therapeutics 02/2012 - 04/2000
2	Immunotherapy 06/2010 - 06/2000
1	Injections 01/2016
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2000
1	Liver Transplantation 04/2000